Heart Rhythm
Volume 6, Issue 2 , Pages 260-262 , February 2009

From nonuniform repolarization to abnormal calcium dynamics: The elusive culprit for ventricular arrhythmias in heart failure

  • Sanjiv M. Narayan, MB, MD, FHRS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Sanjiv M. Narayan, University of California and Veterans Affairs Medical Centers, San Diego, Cardiology 111A, 3350 La Jolla Village Drive, San Diego, California 92161

References 

  1. Zipes D, Camm A, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385–e484
  2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  4. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150
  5. Buxton AE, Lee KL, Carlo LD, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death (Multicenter Unsustained Tachycardia Trial Investigators (MUSTT)). N Engl J Med. 2000;342:1937–1945
  6. Daubert JP, Zareba W, Hall WJ, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006;47:98–107
  7. Weiss JN, Qu Z, Chen P-S, et al. The dynamics of cardiac fibrillation. Circulation. 2005;112:1232–1240
  8. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270–283
  9. Flesch M, Schwinger RH, Schiffer F, et al. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation. 1996;94:992–1002
  10. Gellen B, Fernandez-Velasco M, Briec F, et al. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation. 2008;117:1778–1786
  11. Walker ML, Rosenbaum DS. Cellular alternans as mechanism of cardiac arrhythmogenesis. Heart Rhythm. 2005;2:1383–1386
  12. Mahajan A, Sato D, Shiferaw Y, et al. Modifying L-type calcium current kinetics: consequences for cardiac excitation and arrhythmia dynamics. Biophys J. 2008;94:411–423
  13. Wilson LD, Jeyaraj D, Wan X, et al. Heart failure enhances susceptibility to arrhythmogenic cardiac alternans. Heart Rhythm. 2009;6:251–259
  14. Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias: state of the art paper. J Am Coll Cardiol. 2006;47:269–281
  15. Selvaraj RJ, Picton P, Nanthakumar K, et al. Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T wave alternans. J Am Coll Cardiol. 2007;49:338–346
  16. Sandhu RK, Costantini O, Cummings JE, et al. Intracardiac alternans compared to surface T-wave alternans as a predictor of ventricular arrhythmias in humans. Heart Rhythm. 2008;5:1003–1008
  17. Narayan SM, Bayer J, Lalani G, et al. Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. J Am Coll Cardiol. 2008;52:1782–1792
  18. Pappone C, Santinelli V. Heart failure (The pacing therapy). Minerva Cardioangiol. 2003;51:179–184
  19. Spragg DD, Kass DA. Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis. 2006;49:26–41
  20. Hohnloser SH, Klingenheben T, Bloomfield D, et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol. 2003;41:2220–2224
  21. Chow T, Kereiakes DJ, Onufer J, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? (The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial). J Am Coll Cardiol. 2008;52:1607–1615
  22. Gold MR, Ip JH, Costantini O, et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022–2028
  23. Koller ML, Maier SKG, Gelzer AR, et al. Altered dynamics of action potential restitution and alternans in humans with structural heart disease. Circulation. 2005;112:1542–1548
  24. Klingenheben T, Ptaszynski P, Hohnloser S. Quantitative assessment of microvolt T-wave alternans in patients with congestive heart failure. J Cardiovasc Electrophysiol. 2005;16:620–624
  25. Narayan SM, Lindsay BD, Smith JM. Demonstrating the pro-arrhythmic preconditioning of single premature extrastimuli using the magnitude, phase and temporal distribution of repolarization alternans. Circulation. 1999;100:1887–1893
  26. Narayan SM, Smith JM, Schechtman KB, et al. T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival. Heart Rhythm. 2005;2:234–241
  27. Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007;50:2275–2284
  28. Narayan SM, Bode F, Karasik PL, et al. Alternans of atrial action potentials as a precursor of atrial fibrillation. Circulation. 2002;106:1968–1973
  29. Narayan SM, Kazi D, Krummen DE, et al. Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol. 2008;52:1222–1230

 This work was supported in part by grants from the Doris Duke Charitable Foundation and the National Institutes of Health (HL70529, HL85539). Dr. Narayan has received speaking honoraria and consulting fees from Cambridge Heart, St. Jude Medical, Boston Scientific, Medtronic, Biosense-Webster, and Novartis Corporations.

PII: S1547-5271(08)01180-6

doi: 10.1016/j.hrthm.2008.11.025

Heart Rhythm
Volume 6, Issue 2 , Pages 260-262 , February 2009

Article Tools